Immatics N.V (NASDAQ: IMTX) kicked off on Friday, up 1.30% from the previous trading day, before settling in for the closing price of $5.40. Over the past 52 weeks, IMTX has traded in a range of $5.27-$13.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 90.52% over the last five years. While this was happening, its average annual earnings per share was recorded 46.56%. With a float of $88.97 million, this company’s outstanding shares have now reached $103.11 million.
The firm has a total of 343 workers. Let’s measure their productivity. In terms of profitability, gross margin is 43.41%, operating margin of -58.2%, and the pretax margin is -41.57%.
Immatics N.V (IMTX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Immatics N.V is 25.46%, while institutional ownership is 61.77%.
Immatics N.V (IMTX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.22 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.56% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.02% during the next five years compared to -17.16% drop over the previous five years of trading.
Immatics N.V (NASDAQ: IMTX) Trading Performance Indicators
Take a look at Immatics N.V’s (IMTX) current performance indicators. Last quarter, stock had a quick ratio of 3.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.65, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -1.17 in one year’s time.
Technical Analysis of Immatics N.V (IMTX)
Analysing the last 5-days average volume posted by the [Immatics N.V, IMTX], we can find that recorded value of 1.75 million was better than the volume posted last year of 1.26 million. As of the previous 9 days, the stock’s Stochastic %D was 21.49%. Additionally, its Average True Range was 0.32.
During the past 100 days, Immatics N.V’s (IMTX) raw stochastic average was set at 2.56%, which indicates a significant decrease from 16.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.18% in the past 14 days, which was lower than the 48.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.90, while its 200-day Moving Average is $10.10. Now, the first resistance to watch is $5.57. This is followed by the second major resistance level at $5.67. The third major resistance level sits at $5.78. If the price goes on to break the first support level at $5.37, it is likely to go to the next support level at $5.26. Should the price break the second support level, the third support level stands at $5.16.
Immatics N.V (NASDAQ: IMTX) Key Stats
The company with the Market Capitalisation of 652.88 million has total of 119,356K Shares Outstanding. Its annual sales at the moment are 58,440 K in contrast with the sum of -104,980 K annual income. Company’s last quarter sales were recorded 55,590 K and last quarter income was -9,420 K.
